Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
12.79
+0.64 (5.27%)
At close: Sep 18, 2025, 4:00 PM EDT
12.79
0.00 (0.00%)
After-hours: Sep 18, 2025, 4:00 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $681.67 million as of September 18, 2025. Its market cap has decreased by -43.21% in one year.
Market Cap
681.67M
Enterprise Value
389.29M
1-Year Change
-43.21%
Ranking
Category
Stock Price
$12.79
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $681.67M, an increase of 4.13%. That is a compound annual growth rate of 1.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 647.56M | -11.44% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |